Oral VX-366: Began a Phase I trial

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: Oral VX-366, which raises the levels of fetal hemoglobin Indication: Sickle cell anemia and beta thalassemia Status: Began a Phase I trial...